The fusion peptide domain is the primary membrane-inserted region and enhances membrane interaction of the ectodomain of HIV-1 gp41

Molecular Membrane Biology

Volumn 27, Issue 1, 2010, Pages 31-44

  Cheng, Shu Fang ^a   Chien, Miao Ping ^a   Lin, Chi Hui ^a   Chang, Chung Chieh ^a   Lin, Chun Hung ^a   Liu, Yu Tsan ^a   Chang, Ding Kwo ^a  

^a INSTITUTE OF CHEMISTRY   (Taiwan)

Author keywords

HIV 1 gp41 ectodomain; Membrane fusion; Membrane insertion; Membrane perturbation; Tilt insertion angle

Indexed keywords

GLYCOPROTEIN GP 41; LIPOSOME; MEMBRANE PROTEIN; VIRUS FUSION PROTEIN;

AMINO TERMINAL SEQUENCE; ARTICLE; BILAYER MEMBRANE; EMBEDDING; ENZYME ACTIVITY; ENZYME BINDING; HUMAN IMMUNODEFICIENCY VIRUS 1; HYDROPHOBICITY; MEMBRANE FUSION; MEMBRANE POTENTIAL; MEMBRANE VESICLE; PRIORITY JOURNAL; PROTEIN DOMAIN; PROTEIN INTERACTION;

HUMAN IMMUNODEFICIENCY VIRUS 1;

EID: 72049109704     PISSN: 09687688     EISSN: 14645203     Source Type: Journal    
DOI: 10.3109/09687680903333847     Document Type: Article

References (69)

1. Apellániz B, Nir S, Nieva JL. Distinct mechanisms of lipid bilayer perturbation induced by peptides derived from the membrane-proximal external region of HIV-1 gp41. Biochemistry. 2009;48: 5320-5331.
2. Bacigalupo MA, Ius A, Longhi R, Meroni G. Homogeneous immu-noassay of atrazine in water by terbium-entrapping liposomes as fluorescent markers. Talanta. 2003;61:539-545.
3. Bewley CA, Louis JM, Ghirlando R, Clore GM. Design of a novel peptide inhibitor of HIV fusion that disrupts the internal trimeric coiled-coil of gp41. J Biol Chem. 2002;277:14238-14245.
4. Bonnafous P, Stegmann T. Membrane perturbation and fusion pore formation in influenza hemagglutinin-mediated membrane fusion. A new model for fusion. J Biol Chem. 2000;275:6160-6166.
5. Bradshaw JP, Darkes MJ, Harroun TA, Katsaras J, Epand RM. Oblique membrane insertion of viral fusion peptide probed by neutron diffraction. Biochemistry. 2000;39:6581-6585.
6. Brasseur R, De Loof H, Ruysschaert JM, Rosseneu M. Confor-mational analysis of lipid-associating proteins in a lipid environment. Biochim Biophys Acta. 1988;943:95-102.
7. Bryl K, Kedzierska S, Laskowska M, Taylor A. Membrane fusion by proline-rich Rz1 lipoprotein, the bacteriophage lambda Rz1 gene product. Eur J Biochem. 2000;267:794-799.
8. Burgess SW, McIntosh TJ, Lentz BR. Modulation of poly(ethylene glycol)-induced fusion by membrane hydration: Importance of interbilayer separation. Biochemistry. 1992;31:2653-2661.
9. Caffrey M, Kaufman J, Stahl S, Wingfield P, Gronenborn AM, Clore GM. Monomer-trimer equilibrium of the ectodomain of SIV gp41: Insight into the mechanism of peptide inhibition of HIV infection. Protein Sci. 1999;8:1904-1907.
10. Cao J, Bergeron L, Helseth E, Thali M, Repke H, Sodroski J. Effects of amino acid changes in the extracellular domain of the human immunodeficiency virus type 1 gp41 envelope glycopro-tein. J Virol. 1993;67:2747-2755.
11. Chang DK, Cheng SF. Determination of the equilibrium micelle-inserting position of the fusion peptide of gp41 of human immunodeficiency virus type 1 at amino acid resolution by exchange broadening of amide proton resonances. J Biomol NMR. 1998;12:549-552.
12. Chang DK, Cheng SF, Chien WJ. The amino-terminal fusion domain peptide of human immunodeficiency virus type 1 gp41 inserts into the sodium dodecyl sulfate micelle primarily as a helix with a conserved glycine at the micelle-water interface. J Virol. 1997;71:6593-6602.
13. Chang DK, Cheng SF, Kantchev EA, Lin CH, Liu YT. Membrane interaction and structure of the transmembrane domain of influenza hemagglutinin and its fusion peptide complex. BMC Biol. 2008;6:2.
14. Chang DK, Cheng SF, Trivedi VD. Biophysical characterization of the structure of the amino-terminal region of gp41 of HIV-1. Implications on viral fusion mechanism. J Biol Chem. 1999;274:5299-5309.
15. Chen SS, Lee SF, Hao HJ, Chuang CK. Mutations in the leucine zipper-like heptad repeat sequence of human immunodeficiency virus type 1 gp41 dominantly interfere with wild-type virus infectivity. J Virol. 1998;72:4765-4774.
16. Chen SSL, Yang P, Ke PY, Li HF, Chan WE, Chang DK, Chuang CK, Tsai Y, Huang SC. Identification of the LWYIK motif located in the human immunodeficiency virus type 1 transmem-brane gp41 protein as a distinct determinant for viral infection. J Virol. 2009;83:870-883.
17. Chien MP, Jiang S, Chang DK. The function of coreceptor as a basis for the kinetic dissection of HIV type 1 envelope protein-mediated cell fusion. Faseb J. 2008;22:1179-1192.
18. Durell SR, Martin I, Ruysschaert JM, Shai Y, Blumenthal R. What studies of fusion peptides tell us about viral envelope glycopro-tein-mediated membrane fusion (review). Mol Membr Biol. 1997;14:97-112.
19. Durrer P, Galli C, Hoenke S, Corti C, Gluck R, Vorherr T, Brunner J. H+-induced membrane insertion of influenza virus hemagglutinin involves the HA2 amino-terminal fusion peptide but not the coiled coil region. J Biol Chem. 1996;271:13417-13421.
20. Eisenberg D. Three-dimensional structure of membrane and surface proteins. Annu Rev Biochem. 1984;53:595-623.
21. Freed EO, Delwart EL, Buchschacher GL Jr, Panganiban AT. A mutation in the human immunodeficiency virus type 1 trans-membrane glycoprotein gp41 dominantly interferes with fusion and infectivity. Proc Natl Acad Sci USA. 1992;89:70-74.
22. Freed EO, Myers DJ, Risser R. Characterization of the fusion domain of the human immunodeficiency virus type 1 envelope glycoprotein gp41. Proc Natl Acad Sci USA. 1990;87: 4650-4654.
23. Furuta RA, Wild CT, Weng Y, Weiss CD. Capture of an early fusion-active conformation of HIV-1 gp41. Nat Struct Biol. 1998;5:276-279.
24. Gawrisch K, Ruston D, Zimmerberg J, Parsegian VA, Rand RP, Fuller N. Membrane dipole potentials, hydration forces, and the ordering of water at membrane surfaces. Biophys J. 1992;61: 1213-1223.
25. Ge M, Freed JH. Fusion peptide from influenza hemagglutinin increases membrane surface order: An electron-spin resonance study. Biophys J. 2009;96:4925-4934.
26. Han X, Steinhauer DA, Wharton SA, Tamm LK. Interaction of mutant influenza virus hemagglutinin fusion peptides with lipid bilayers: Probing the role of hydrophobic residue size in the central region of the fusion peptide. Biochemistry. 1999;38:15052-15059.
27. Harter C, James P, Bachi T, Semenza G, Brunner J. Hydrophobic binding of the ectodomain of influenza hemagglutinin to membranes occurs through the 'fusion peptide'. J Biol Chem. 1989;264:6459-6464.
28. He Y, Cheng J, Lu H, Li J, Hu J, Qi Z, Liu Z, Jiang S, Dai Q. Potent HIV fusion inhibitors against Enfuvirtide-resistant HIV-1 strains. Proc Natl Acad Sci USA. 2008;105:16332-16337.
29. Helm CA, Israelachvili JN, McGuiggan PM. Molecular mechanisms and forces involved in the adhesion and fusion of amphi-philic bilayers. Science. 1989;246:919-922.
30. Hernandez LD, Hoffman LR, Wolfsberg TG, White JM. Virus-cell and cell-cell fusion. Annu Rev Cell Dev Biol. 1996;12: 627-661.
31. Huang W, Toma J, Fransen S, Stawiski E, Reeves JD, Whitcomb JM, Parkin N, Petropoulos CJ. Coreceptor tropism can be influenced by amino acid substitutions in the gp41 transmembrane subunit of human immunodeficiency virus type 1 envelope protein. J Virol. 2008;82:5584-5593.
32. Jaroniec CP, Kaufman JD, Stahl SJ, Viard M, Blumenthal R, Wingfield PT, Bax A. Structure and dynamics of micelle-associated human immunodeficiency virus gp41 fusion domain. Biochemistry. 2005;44:16167-16180.
33. Kantchev EA, Cheng SF, Wu CW, Huang HJ, Chang DK. Secondary structure, phospholipid membrane interactions, and fusion activity of two glutamate-rich analogs of influenza hem-agglutinin fusion peptide. Arch Biochem Biophys. 2004;425:173-183.
34. Korazim O, Sackett K, Shai Y. Functional and structural characterization of HIV-1 gp41 ectodomain regions in phospholipid membranes suggests that the fusion-active conformation is extended. J Mol Biol. 2006;364:1103-1117.
35. Lakowicz JR. 1983. Principles of fluorescence spectrosopy. New York: Plenum Press.
36. Lev N, Fridmann-Sirkis Y, Blank L, Bitler A, Epand RF, Epand RM, Shai Y. Conformational stability and membrane interaction of the full-length ectodomain of HIV-1 gp41: Implication for mode of action. Biochemistry. 2009;48: 3166-3175.
37. Lev N, Shai Y. Fatty acids can substitute the HIV fusion peptide in lipid merging and fusion: An analogy between viral and palmitoy-lated eukaryotic fusion proteins. J Mol Biol. 2007;374:20-230.
38. Lin CH, Chang CC, Cheng SF, Chang DK. The application of perfluorooctanoate to investigate trimerization of the human immunodeficiency virus-1 gp41 ectodomain by electrophoresis. Electrophoresis. 2008;29:3175-3182.
39. Lis LJ, McAlister M, Fuller N, Rand RP, Parsegian VA. Interactions between neutral phospholipid bilayer membranes. Biophys J. 1982;37:657-665.
40. Luneberg J, Martin I, Nussler F, Ruysschaert JM, Herrmann A. Structure and topology of the influenza virus fusion peptide in lipid bilayers. J Biol Chem. 1995;270:27606-27614.
41. Maddon PJ, Dalgleish AG, McDougal JS, Clapham PR, Weiss RA, Axel R. The T4 gene encodes the AIDS virus receptor and is expressed in the immune system and the brain. Cell. 1986;47: 333-348.
42. Marsh M, Helenius A. Virus entry into animal cells. Adv Virus Res. 1989;36:107-1051.
43. Martin I, Dubois MC, Defrise-Quertain F, Saermark T, Burny A, Brasseur R, Ruysschaert JM. Correlation between fusogenicity of synthetic modified peptides corresponding to the NH2-terminal extremity of simian immunodeficiency virus gp32 and their mode of insertion into the lipid bilayer: An infrared spectroscopy study. J Virol. 1994;68:1139-1148.
44. Martin II, Ruysschaert J, Epand RM. Role of the N-terminal peptides of viral envelope proteins in membrane fusion. Adv Drug Deliv Rev. 1999;38:233-255.
45. Mobley PW, Pilpa R, Brown C, Waring AJ, Gordon LM. Membrane-perturbing domains of HIV type 1 glycoprotein 41. AIDS Res Hum Retroviruses. 2001;17:311-327.
46. Moreno MR, Guillen J, Perez-Berna AJ, Amoros D, Gomez AI, Bernabeu A, Villalain J. Characterization of the interaction of two peptides from the N terminus of the NHR domain of HIV-1 gp41 with phospholipid membranes. Biochemistry. 2007;46: 10572-10584.
47. Moreno MR, Perez-Berna AJ, Guillen J, Villalain J. Biophysical characterization and membrane interaction of the most membra-notropic region of the HIV-1 gp41 endodomain. Biochim Bio-phys Acta. 2008;1778:1298-1307.
48. Morris SJ, Bradley D, Blumenthal R. The use of cobalt ions as a collisional quencher to probe surface charge and stability of fluorescently labeled bilayer vesicles. Biochim Biophys Acta. 1985;818:365-372.
49. Navratilova I, Pancera M, Wyatt RT, Myszka DG. A biosensor-based approach toward purification and crystallization of G protein-coupled receptors. Anal Biochem. 2006;353:278-283.
50. Pereira FB, Goni FM, Muga A, Nieva JL. Permeabilization and fusion of uncharged lipid vesicles induced by the HIV-1 fusion peptide adopting an extended conformation: Dose and sequence effects. Biophys J. 1997;73:1977-1986.
51. Rand RP. Interacting phospholipid bilayers: Measured forces and induced structural changes. Annu Rev Biophys Bioeng. 1981;10:277-314.
52. Rapaport D, Shai Y. Interaction of fluorescently labeled pardaxin and its analogues with lipid bilayers. J Biol Chem. 1991;266:23769-23775.
53. Rizzuto CD, Wyatt R, Hernandez-Ramos N, Sun Y, Kwong PD, Hendrickson WA, Sodroski J. A conserved HIV gp120 glycoprotein structure involved in chemokine receptor binding. Science. 1998;280:1949-1953.
54. Saez-Cirion A, Arrondo JL, Gomara MJ, Lorizate M, Iloro I, Melikyan G, Nieva JL. Structural and functional roles of HIV-1 gp41 pretransmembrane sequence segmentation. Biophys J. 2003;85:3769-3780.
55. Sattentau QJ, Moore JP. Conformational changes induced in the human immunodeficiency virus envelope glycoprotein by soluble CD4 binding. J Exp Med. 1991;174:407-415.
56. Schaal H, Klein M, Gehrmann P, Adams O, Scheid A. Requirement of N-terminal amino acid residues of gp41 for human immunodeficiency virus type 1-mediated cell fusion. J Virol. 1995;69:3308-3314.
57. Sollner T, Bennett MK, Whiteheart SW, Scheller RH, Rothman JE. A protein assembly-disassembly pathway in vitro that may correspond to sequential steps of synaptic vesicle docking, activation, and fusion. Cell. 1993;75:409-418.
58. Stegmann T, Delfino JM, Richards FM, Helenius A. The HA2 subunit of influenza hemagglutinin inserts into the target membrane prior to fusion. J Biol Chem. 1991;266: 18404-18410.
59. Struck DK, Hoekstra D, Pagano RE. Use of resonance energy transfer to monitor membrane fusion. Biochemistry. 1981;20:4093-4099.
60. Sullivan N, Sun Y, Binley J, Lee J, Barbas CF 3rd, Parren PW, Burton DR, Sodroski J. Determinants of human immunodeficiency virus type 1 envelope glycoprotein activation by soluble CD4 and monoclonal antibodies. J Virol. 1998;72: 6332-6338.
61. Tamm LK, Tatulian SA. Infrared spectroscopy of proteins and peptides in lipid bilayers. Q Rev Biophys. 1997;30:365-429.
62. Tristram-Nagle S, Nagle JF. HIV-1 fusion peptide decreases bending energy and promotes curved fusion intermediates. Biophys J. 2007;93:2048-2055.
63. Viard M, Ablan SD, Zhou M, Veenstra TD, Freed EO, Raviv Y, Blumenthal R. Photoinduced reactivity of the HIV-1 envelope glycoprotein with a membrane-embedded probe reveals insertion of portions of the HIV-1 Gp41 cytoplasmic tail into the viral membrane. Biochemistry. 2008;47:1977-1983.
64. Vishwanathan SA, Hunter E. Importance of the membrane-perturbing properties of the membrane-proximal external region of human immunodeficiency virus type 1 gp41 to viral fusion. J Virol. 2008;82:5118-51126.
65. White JM, Delos SE, Brecher M, Schornberg K. Structures and mechanisms of viral membrane fusion proteins: Multiple variations on a common theme. Crit Rev Biochem Mol Biol. 2008;43:189-219.
66. Yu YG, King DS, Shin YK. Insertion of a coiled-coil peptide from influenza virus hemagglutinin into membranes. Science. 1994;266:274-276.
67. Zheng Z, Yang R, Bodner ML, Weliky DP. Conformational flexibility and strand arrangements of the membrane-associated HIV fusion peptide trimer probed by solid-state NMR spectroscopy. Biochemistry. 2006;45:12960-12975.
68. Lev N, Fridmann-Sirkis Y, Blank L, Bitler A, Epand RF, Epand RM, Shai Y. Conformational stability and membrane interaction of the full-length ectodomain of HIV-1 gp41: Implication for mode of action. Biochemistry. 2009;48: 3166-3175.
69. Lin CH, Chang CC, Cheng SF, Chang DK. The application of perfluorooctanoate to investigate trimerization of the human immunodeficiency virus-1 gp41 ectodomain by electrophoresis. Electrophoresis. 2008;29:3175-3182.